Orally administration of 100 or 200 mg/kg berberine had renoprotective effects owing to decreased ICAM-1 and VCAM-1 levels and increased β-arrestin 1 and 2 in kidneys of a rat model of DN (Tang et al., 2016). The gene discussed is VCAM1; the disease is liver dysplastic nodule.